Dror Bashan | President and CEO |
Eyal Rubin | SVP and CFO |
Chuck Padala | LifeSci Advisors, IR |
Boobalan Pachaiyappan | H.C. Wainwright |
John Vandermosten | Zacks |
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Third Quarter 2021 Financial Results and Business Update Conference Call.
As a reminder, this conference is being recorded. I would now like to turn the conference over to our host, Mr. Chuck Padala of LifeSci Advisors, Investor Relations for Protalix. Thank you.